Instil Bio, Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline includ…
Biotechnology
US, Dallas [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Instil Bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDInstil Bio, Inc. can't present revenue by segment